Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

A comparison of 4 epinephrine autoinjector delivery systems: usability and patient preference.

Guerlain S, Hugine A, Wang L.

Ann Allergy Asthma Immunol. 2010 Feb;104(2):172-7. doi: 10.1016/j.anai.2009.11.023.

2.

Intelliject's novel epinephrine autoinjector: sharps injury prevention validation and comparable analysis with EpiPen and Twinject.

Guerlain S, Wang L, Hugine A.

Ann Allergy Asthma Immunol. 2010 Dec;105(6):480-4. doi: 10.1016/j.anai.2010.09.028.

3.

Auvi-Q versus EpiPen: preferences of adults, caregivers, and children.

Camargo CA Jr, Guana A, Wang S, Simons FE.

J Allergy Clin Immunol Pract. 2013 May-Jun;1(3):266-72.e1-3. doi: 10.1016/j.jaip.2013.02.004. Epub 2013 Apr 9.

PMID:
24565484
4.

Patients' ability to treat anaphylaxis using adrenaline autoinjectors: a randomized controlled trial.

Umasunthar T, Procktor A, Hodes M, Smith JG, Gore C, Cox HE, Marrs T, Hanna H, Phillips K, Pinto C, Turner PJ, Warner JO, Boyle RJ.

Allergy. 2015 Jul;70(7):855-63. doi: 10.1111/all.12628. Epub 2015 Apr 16.

5.

A randomized maternal evaluation of epinephrine autoinjection devices.

Brown J, Tuthill D, Alfaham M, Spear E.

Pediatr Allergy Immunol. 2013 Mar;24(2):173-7. doi: 10.1111/pai.12048. Epub 2013 Mar 1.

PMID:
23448513
6.

Make-up of the epinephrine autoinjector: the effect on its use by untrained users.

Bakirtas A, Arga M, Catal F, Derinoz O, Demirsoy MS, Turktas I.

Pediatr Allergy Immunol. 2011 Nov;22(7):729-33. doi: 10.1111/j.1399-3038.2011.01195.x. Epub 2011 Jul 13.

PMID:
21749463
7.

Design validation and labeling comprehension study for a new epinephrine autoinjector.

Edwards ES, Edwards ET, Gunn R, Patterson P, North R.

Ann Allergy Asthma Immunol. 2013 Mar;110(3):189-193.e1. doi: 10.1016/j.anai.2012.12.008. Epub 2013 Jan 11.

PMID:
23548530
8.

Comparison of adrenaline auto-injector devices: ease of use and ability to recall use.

Robinson MN, Dharmage SC, Tang ML.

Pediatr Allergy Immunol. 2014 Aug;25(5):462-7. doi: 10.1111/pai.12261.

PMID:
25041111
9.

First aid anaphylaxis management in children who were prescribed an epinephrine autoinjector device (EpiPen).

Gold MS, Sainsbury R.

J Allergy Clin Immunol. 2000 Jul;106(1 Pt 1):171-6.

PMID:
10887321
10.

Lacerations and Embedded Needles Caused by Epinephrine Autoinjector Use in Children.

Brown JC, Tuuri RE, Akhter S, Guerra LD, Goodman IS, Myers SR, Nozicka C, Manzi S, Long K, Turner T, Conners GP, Thompson RW, Park E.

Ann Emerg Med. 2016 Mar;67(3):307-315.e8. doi: 10.1016/j.annemergmed.2015.07.011. Epub 2015 Oct 9.

PMID:
26452720
11.

Treatment of anaphylaxis: EpiPen, Twinject, or another autoinjector?

Ackaoui A.

Can Fam Physician. 2011 Mar;57(3):273-4. English, French. No abstract available.

12.

Demonstration of epinephrine autoinjectors (EpiPen and Anapen) by pharmacists in a randomised, simulated patient assessment: acceptable, but room for improvement.

Salter SM, Loh R, Sanfilippo FM, Clifford RM.

Allergy Asthma Clin Immunol. 2014 Sep 19;10(1):49. doi: 10.1186/1710-1492-10-49. eCollection 2014.

13.

Pharmacists' response to anaphylaxis in the community (PRAC): a randomised, simulated patient study of pharmacist practice.

Salter SM, Delfante B, de Klerk S, Sanfilippo FM, Clifford RM.

BMJ Open. 2014 Jul 9;4(7):e005648. doi: 10.1136/bmjopen-2014-005648.

14.

Use of epinephrine autoinjectors for treatment of anaphylaxis: which commercially available autoinjector do patients prefer?

Baker TW, Stolfi A, Johnson TL.

Ann Allergy Asthma Immunol. 2009 Oct;103(4):356-8. doi: 10.1016/S1081-1206(10)60539-X. No abstract available.

PMID:
19856492
15.

Usability and Acceptability of the Abatacept Pre-Filled Autoinjector for the Subcutaneous Treatment of Rheumatoid Arthritis.

Schiff M, Koo J, Jin E, Schiller E, Day A, Stevens R, Laskar C.

Adv Ther. 2016 Feb;33(2):199-213. doi: 10.1007/s12325-016-0286-9. Epub 2016 Jan 30.

16.

Outdated EpiPen and EpiPen Jr autoinjectors: past their prime?

Simons FE, Gu X, Simons KJ.

J Allergy Clin Immunol. 2000 May;105(5):1025-30.

PMID:
10808186
17.

Variability in syringe components and its impact on functionality of delivery systems.

Rathore N, Pranay P, Eu B, Ji W, Walls E.

PDA J Pharm Sci Technol. 2011 Sep-Oct;65(5):468-80. doi: 10.5731/pdajpst.2011.00785.

PMID:
22293836
18.

Adequacy of the epinephrine autoinjector needle length in delivering epinephrine to the intramuscular tissues.

Song TT, Nelson MR, Chang JH, Engler RJ, Chowdhury BA.

Ann Allergy Asthma Immunol. 2005 May;94(5):539-42.

PMID:
15945556
19.

Autoinjectors Preferred for Intramuscular Epinephrine in Anaphylaxis and Allergic Reactions.

Campbell RL, Bellolio MF, Motosue MS, Sunga KL, Lohse CM, Rudis MI.

West J Emerg Med. 2016 Nov;17(6):775-782. Epub 2016 Oct 7.

20.

Hazards of unintentional injection of epinephrine from autoinjectors: a systematic review.

Simons FE, Lieberman PL, Read EJ Jr, Edwards ES.

Ann Allergy Asthma Immunol. 2009 Apr;102(4):282-7. doi: 10.1016/S1081-1206(10)60332-8. Review.

PMID:
19441598

Supplemental Content

Support Center